Predictive value of serum androstenedione basal levels on the choice of gonadotropin or laparoscopic ovarian electrocautery as ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome

References

• Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983; 62: 196–202
   PubMed Web of Science ®Google Scholar
• Wang CF, Gemzell C. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril 1980; 33: 479
   PubMedGoogle Scholar
• Check JH, Wu CH, Gocial B, et al. Severe ovarian hyperstimulation syndrome from treatment with urinary follicle-stimulating hormone: two cases. Fertil Steril 1985; 43: 317
   PubMedGoogle Scholar
• Abdel Gadir A, Mowafi RS, Alnaser HMI, et al. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol 1990; 33: 585–92
   PubMed Web of Science ®Google Scholar
• Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovaries. Fertil Steril 1995; 63: 439–63
   PubMed Web of Science ®Google Scholar
• Vicino M, Loverro G, Bettocchi S, et al. Clomiphene citrate-resistant infertile patients with polycystic ovary syndrome. Laparoscopic ovarian electrocautery vs pure follicle stimulating hormone therapy: which the best choice?. Gynecol Endocrinol 1996; 10(suppl 4)178
   Google Scholar
• Adashi EY, Rock JA, Guzick D, et al. Fertility following bilateral ovarian wedge resection; a critical analysis of 90 consecutive cases of polycystic ovary syndrome. Fertil Steril 1981; 36: 320–5
   PubMed Web of Science ®Google Scholar
• Abdel Gadir A, Khatim MS, Alnaser HM, et al. Ovarian electrocautery: responders versus non-responders. Gynecol Endocrinol 1993; 7: 43–8
   PubMed Web of Science ®Google Scholar
• Singh KB, Mahajan DK, Wortsman J. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. J Reprod Med 1994; 39: 805–8
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Ragni G, Parazzini F. Anthropometric indicators and response to gonadotrophin for ovulation induction. Hum Reprod 1994; 9: 420–3
   PubMed Web of Science ®Google Scholar
• McClure N, McQuinn B, McDonald J, et al. Body weight, body mass index and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?. Fertil Steril 1992; 58: 622–4
   PubMed Web of Science ®Google Scholar
• White DM, Poison DW, Kiddy D, et al. Extensive personal experience. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996; 81: 3821–4
   PubMed Web of Science ®Google Scholar
• Gjonnaess H. Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results. Acta Obstet Gynecol Scand 1994; 73: 407–12
   PubMed Web of Science ®Google Scholar
• Fahri J, Soule S, Jacobs HS. Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 1995; 64: 930–5
   PubMedGoogle Scholar
• Adams J, Franks S, Poison DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin-releasing hormone. Lancet 1985; 2: 1375–8
   PubMed Web of Science ®Google Scholar
• Gjonnaess H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 1984; 41: 20–5
   PubMed Web of Science ®Google Scholar
• Tiitinen AE, Laatikainen TJ, Seppala M. Serum levels of insulin-like growth factor binding protein I and ovulatory response to clomiphene citrate in women with polycystic ovary disease. Fertil Steril 1993; 60: 58–62
   PubMed Web of Science ®Google Scholar
• Hamilton-Fairley D, Kiddy D, Watson H, et al. Association of moderate obesity with poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophins. Br J Obstet Gynaecol 1993; 99: 128–31
   Google Scholar
• Kiddy D, Sharp PS, White DM, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol 1990; 32: 213–20
   PubMed Web of Science ®Google Scholar
• Suikkari AM, MacLachlan V, Montalto J, et al. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment. Hum Reprod 1995; 10: 513–9
   PubMedGoogle Scholar
• Greenblatter E, Casper RF. Endocrine changes after laparoscopic ovarian electrocautery in polycystic ovary syndrome. Am J Obstet Gynecol 1987; 42: 517–8
   Google Scholar
• Abdel Gadir A, Khatim MS, Mowafi RS, et al. Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization. Clin Endocrinol 1990; 32: 749–54
   PubMedGoogle Scholar
• Armar NA, McGarrigie HHG, Honour JW, et al. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril 1990; 53: 45–9
   PubMed Web of Science ®Google Scholar
• Rossmanith WG, Keckstein J, Spatzier K, et al. The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease. Clin Endocrinol 1991; 34: 223–30
   PubMed Web of Science ®Google Scholar
• Abdel Gadir A, Alnaser HMI, Mowafi RS, et al. The response of patients with polycystic ovarian disease to human menopausal gonadotrophin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist. Fertil Steril 1992; 57: 309–13
   PubMed Web of Science ®Google Scholar
• Armar NA, Lachelin GCL. Laparoscopic ovarian diathermy: an effective treatment for antioestrogen resistant anovulatory infertility in women with polycystic ovaries. Br J Obstet Gynaecol 1993; 100: 161–4
   PubMedGoogle Scholar
• Dunaif A, Mandeli J, Flhur H, et al. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab 1988; 66: 131–9
   PubMed Web of Science ®Google Scholar